NAMS · Categories · Form 3

NAMS - SEC Form 3 initial insider statements

NewAmsterdam Pharma Company N.V. (NAMS) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for NAMS

• 371d
  SEC Form 3 filed by new insider Marino Michael F Iii

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 418d
  SEC Form 3 filed by new insider Gulfo Adele M.

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 690d
  SEC Form 3 filed by new insider Mckenna Mark C.

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 690d
  SEC Form 3 filed by new insider Joustra Wouter

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 767d
  SEC Form 3 filed by new insider Jones William A Jr

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 866d
  New insider Lange Louis G claimed ownership of 19,878 units of Ordinary Shares (SEC Form 3) (Amendment)

  3/A - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 866d
  SEC Form 3 filed by new insider Davidson Michael H. (Amendment)

  3/A - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 883d
  SEC Form 3 filed by new insider Lewis William

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 889d
  New insider Forgrowth Nap B.V. claimed ownership of 11,831,461 units of Ordinary Shares (SEC Form 3)

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  New insider Bain Capital Life Sciences Investors, Llc claimed ownership of 10,473,913 units of Ordinary Shares (SEC Form 3)

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Downing Nicholas

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  New insider Topper James N claimed ownership of 6,801,000 units of Ordinary Shares (SEC Form 3)

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Audet Juliette Berangere

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Smither John W

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Slootweg Hugo Alexander

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Kastelein Johannes Jacob Pieter

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Kling Douglas F

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  New insider Lange Louis G claimed ownership of 9,878 units of Ordinary Shares (SEC Form 3)

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Somaiya Mayur Ian

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  New insider Davidson Michael H. claimed ownership of 808,563 units of Ordinary Shares (SEC Form 3)

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Kooij Louise Frederika

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)
• 893d
  SEC Form 3 filed by new insider Van Der Kamp Hilde Johanna

  3 - NewAmsterdam Pharma Co N.V. (0001936258) (Issuer)

Other NAMS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends